The UK will join the USA, Canada, Australia, Switzerland, Singapore and Brazil to speed up the approval of innovative medicines. International regulators will work together to authorise promising treatments after the EU transition period Medicines will include cancer treatments NHS patients could have quicker access to the next generation of cutting-edge treatments thanks to the […]
Medilink WM patron MasterControl provides an informative article, highlighting to industry that software must not be overlooked when considering MDR requirements and compliance.
30th January 2019
The Medicines and Healthcare products Regulatory Agency (MHRA) have provided details of legislation to ensure continuity of supply of medicines, medical devices and clinical trials in a no deal Brexit.